Dangers of rosuvastatin identified before and after FDA approval [1]

Sidney M. Wolfe

doi:10.1016/S0140-6736(04)16513-6

Dangers of rosuvastatin identified before and after FDA approval [1]

Sidney M. Wolfe

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

61 Scopus citations

Original language	English (US)
Pages (from-to)	2189-2190
Number of pages	2
Journal	Lancet
Volume	363
Issue number	9427
DOIs	https://doi.org/10.1016/S0140-6736(04)16513-6
State	Published - Jun 26 2004

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(04)16513-6

Cite this

@article{f51a7e138daa45b2b1e6ae6184793539,

title = "Dangers of rosuvastatin identified before and after FDA approval [1]",

author = "Wolfe, {Sidney M.}",

year = "2004",

month = jun,

day = "26",

doi = "10.1016/S0140-6736(04)16513-6",

language = "English (US)",

volume = "363",

pages = "2189--2190",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9427",

}

TY - JOUR

T1 - Dangers of rosuvastatin identified before and after FDA approval [1]

AU - Wolfe, Sidney M.

PY - 2004/6/26

Y1 - 2004/6/26

UR - http://www.scopus.com/inward/record.url?scp=3042604519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042604519&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(04)16513-6

DO - 10.1016/S0140-6736(04)16513-6

M3 - Letter

C2 - 15220045

AN - SCOPUS:3042604519

SN - 0140-6736

VL - 363

SP - 2189

EP - 2190

JO - Lancet

JF - Lancet

IS - 9427

ER -

Dangers of rosuvastatin identified before and after FDA approval [1]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this